DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis Dtsch Med Wochenschr 2011; 136(46): 2361-2366DOI: 10.1055/s-0031-1292052 Übersicht | Review article Hypertonologie © Georg Thieme Verlag KG Stuttgart · New York Blutdruckvariabilität Diagnostik, prognostische Bedeutung und therapeutische KonsequenzenBlood pressure variabilityDiagnosis, prognostic implications and consequences for treatmentM. Middeke1 1Hypertoniezentrum München Artikel empfehlen Abstract Artikel einzeln kaufen Schlüsselwörter Blutdruckvariabilität - Blutdruckrhythmus - Blutdruckschwankungen - Chronopathologie Keywords blood pressure variability - rhythm of blood pressure - circadian rhythm - chronopathology Volltext Referenzen Literatur 1 Anlauf M, Baumgart P, Krönig B, Meyer-Sabellek W, Middeke M, Schrader J. Statement zur „24-Stunden-Blutdruckmessung“ der Deutschen Liga zur Bekämpfung des hohen Blutdruckes. Z Kardiol. 1991; 80,Suppl.1 53-55 2 Anlauf M, Baumgart P, Franz I, Gotzen R, Krönig B, Meyer-Sabellek W, Middeke M, Schrader J, Schulte K L, Weber F. Statement on ambulatory blood pressure monitoring by the German Hypertension League. J Hum Hypertens. 1995; 9 777-779 3 Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-h average blood pressure. Hypertension. 1983; 5 264-269 4 Dolan E, Stanton A, Thijs L. et al . Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005; 46 156-161 5 Fugiwara T. et al . Seasonal differences in diurnal blood pressure of hypertensive patients living in a stable environmental temperature. J Hypertens. 1995; 13 1747-1752 6 Hansen T W, Thijs L, Li Y. et al . Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010; 55 1049-1057 7 Hermida R C, Ayala D E, Mojon A, Fernandez J R. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010; 27 1629-1651 8 Johansson J K, Niiranen T J, Puukka P J, Jula A M. Factors affecting the variability of home-measured blood pressure and heart: the Finn-home study. J Hypertens. 2010; 28 1836-1845 9 Johansson J K, Niiranen T J, Puukka P J, Jula A M. Optimal schedule for home blood pressure monitoring based on a clinical approach. J Hypertens. 2010; 28 259-264 10 Katsch G, Pansdorf H. Die Schlafbewegung des Blutdrucks. Münch Med Wochenschr. 1922; 69 1715-1718 11 Kikuya M, Hozawa A, Ohokubo T. et al . Prognostic significance of blood pressure and heart rate variabilities. Hypertension. 2000; 38 23-29 12 Kikuya M, Ohkubo T, Metoki H. et al . Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis. Hypertension. 2008; 52 1045-1050 13 Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease – from mice and man. Pharmcol & Therapeutics. 2006; 111 629-651 14 Mancia G, Bombelli M, Facchetti. et al . Long-term prognostic value of blood pressure variability in the general population: results of the PAMELA study. Hypertension. 2000; 49 1265-1270 15 Mengden T, Hernandez Medina R M, Beltran B. et al . Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens. 1998; 11 1413-1417 16 Middeke M, Klüglich M, Holzgreve H. Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing. Chronobiology International. 1991; 8 506-510 17 Middeke M, Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension. BMJ. 1994; 308 630-632 18 Middeke M. Chronopathology of blood pressure in the early stage of hypertension. From the biological clock to chronopharmacology. 8th ed.. In: Lemmer Stuttgart: Medpharm. Sci. Publ; 1996: 119-128. 19 Middeke M. Drug effects on blood pressure rhythm in secondary hypertension. Annals NY Academy of Science. 1996; 783 270-277 20 Middeke M. Telemetrische Blutdruck- und Therapiekontrolle. Klinikarzt. 2009; 38 146-150 21 Middeke M. Hochdruckwarnung per SMS. MMW-Fortschr Med. 2010; 152 47-49 22 Middeke M. Antihypertensive Chronotherapie. Chronopathologie renaler Hochdruckformen. Dialyse aktuell. 2010; 14 98-105 23 Ohkubo T, Asayama K, Kikuya M. et al . How many times should blood pressure be measured for at home for better prediction of stroke risk?. J Hypertens. 2004; 22 1099-1104 24 Ohkubo T, Imai Y, Tsuji I. et al . Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements. J Hypertens. 1997; 15 357-364 25 Parati G, Pomidossi G, Albini F. et al . Relationship of 24-h blood pressure mean and variability to severity of target organ damage. J Hypertens. 1987; 5 93-98 26 Parati G, Stergiou G S, Asmar R. et al . ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference of Home Blood Pressure Monitoring. J Hypertens. 2008; 26 1505-1526 27 Piesbergen C, Middeke M, Butollo W. Online-Feedback des Blutdrucks mittels nichtinvasiver, kontinuierlicher Blutdruckmessung. Nieren- und Hochdruckkrankheiten. 1995; 3 154-156 28 Pringle E, Phillips C, Thijs L. et al, On behalf of the Syst-Eur investigators . Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens. 2003; 21 2251-2257 29 Rothwell P M, Howard S C, Dolan E. et al . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375 895-905 30 Rothwell P M, Howard S C, Dolan E. et al . Effects of ß blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurology. 2010; 9 469-480 31 Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation. 2000; 102 1536-141 32 Staessen J A, OŽBrien E T, Atkins N. et al . Short report: Ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens. 1994; 12 (Suppl 7) S1-S12 33 Stergiou G, Nasothimious E G, Kalogeropoulos P G. et al . The optimal home blood pressure monitoring schedule based on the Didima outcome study. J Hum Hypertens. 2009; 24 158-164 34 Trazzi S, Mutti E, Frattola A. et al . Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens. 1991; 9 115-119 35 Webb A JS, Fischer U, Mehta Z, Rothwell P M. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010; 375 906-915 Prof. Dr. med. Martin Middeke Hypertoniezentrum MünchenHypertension Excellence Center of the European Society of Hypertension ESH Dienerstr. 12 80331 München Telefon: 089/36103947 Fax: 089/36104026 URL: http://www.hypertoniezentrum.de
